Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Two deputy commissioners depart FDA. NICE takes over U.K. program to encourage adoption of new medical technologies. More news.

You may also be interested in...



FDA Ready To Hire New Deputy Commissioner For Medical Products And Tobacco

The winning candidate would be the third to hold the position in two years. The job notice will be corrected, though – top secret clearance is not required.

St. Jude Medical: Cardiac Rhythm Management Business Has “Turned The Corner”

The firm reported during its second-quarter earnings call that its cardiac rhythm management business has stabilized after several quarters of market share decline.

Boston Scientific Subsidiaries Barred From Selling Multiple Drug-Eluting Stent Lines In Germany

A German court had previously blocked Boston Scientific’s German subsidiary from selling drug-eluting stents affected by OrbusNeich’s patent suit; the new injunction closes a loophole, preventing any Boston Scientific subsidiary from selling the devices in Germany.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT032020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel